PerkinElmer (0KHE.L) Stock Price

$100.7 0.5%

Sign up
to add to portfolio

AI Score

Hold

  • Alternative

    4

  • Fundamental

    4

  • Technical

    5

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on PerkinElmer, AI stock picks, stock alerts and much more.

Sign up

0KHE.L AI Stock Analysis

AI stock analysis for 0KHE.L is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like PerkinElmer (0KHE.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

PerkinElmer (0KHE.L) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of PerkinElmer (0KHE.L), currently trading at $100.7, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About 0KHE.L

LSE

  • PerkinElmer, Inc.

  • Symbol

    0KHE.L

  • Market

    LSE

  • Industry

    Medical - Diagnostics & Research

  • Market Cap

    11.9B

Similar Stocks

0QNO.L Lonza Group AG
0QNO.L		 CHF560.4
0.5%
5
AGL.L ANGLE
AGL.L		 £5.75
9.5%
3
DXRX.L Diaceutics PLC
DXRX.L		 £116.5
2.1%
7
GDR.L genedrive
GDR.L		 £1.43
1.8%
3
VRCI.L Verici Dx
VRCI.L		 £1.13
10.2%
5

News

Spatial Proteomics Market Analysis 2025-2030: Total Revenues to Surpass $189 Million by 2030, Driven by the Growing Demand for Precision Medicine

Spatial Proteomics Market Analysis 2025-2030: Total Revenues to Surpass $189 Million by 2030, Driven by the Growing Demand for Precision Medicine
February 11, 2025. GlobeNewswire
Electrophoresis Reagents Strategic Business Report 2024 - Gels Segment is Forecast to Reach US$709.2 Million by 2030 with a CAGR of a 5.7%

Electrophoresis Reagents Strategic Business Report 2024 - Gels Segment is Forecast to Reach US$709.2 Million by 2030 with a CAGR of a 5.7%
December 9, 2024. GlobeNewswire
# Evolv Technology Holdings CEO terminated, replaced by Michael Ellenbogen as Interim CEO

# Evolv Technology Holdings CEO terminated, replaced by Michael Ellenbogen as Interim CEO
November 2, 2024. ETF Daily News
PFAS (Per- and Polyfluoroalkyl Substances) Testing Research Report 2024-2034: Advanced Testing Methods for Forever Chemicals See Surge in Demand Amid Global Contamination Concerns

PFAS (Per- and Polyfluoroalkyl Substances) Testing Research Report 2024-2034: Advanced Testing Methods for Forever Chemicals See Surge in Demand Amid Global Contamination Concerns
October 14, 2024. GlobeNewswire

0KHE.L Alternative Data

Web Traffic

PerkinElmer receives an estimated 171670 monthly visitors to perkinelmer.com, which is down by -1.5% over the last month.

  • Web Traffic

    171670

  • Change from Previous Month

    1.5%

  • 3 Month Change

    10.1%

  • YoY Change

    10.1%

Twitter Followers

PerkinElmer has 9,399 Twitter Followers on its main Twitter (also known as X) account, which is up by 0% over the last month.

  • Twitter Followers

    9399

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0.7%

Facebook Engagement

PerkinElmer has engaged 6 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    6

  • Daily Change

    14.3%

  • 1 Month Change

    60%

  • 3 Month Change

    25%

Instagram Followers

PerkinElmer has 5,101 Instagram Followers on its main Instagram account, up by 0.2% over the last month.

  • Instagram Followers

    5101

  • Daily Change

    0%

  • 1 Month Change

    0.2%

  • 3 Month Change

    1.1%

Youtube Subscribers

PerkinElmer has 14,600 subscribers on its main Youtube channel, up by 0.7% over the last month.

  • Youtube Subscribers

    14600

  • Daily Change

    0%

  • 1 Month Change

    0.7%

  • 3 Month Change

    1.4%

Reddit Mentions

PerkinElmer has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

LinkedIn Followers

201,911 are following PerkinElmer on LinkedIn, up by 0.8% over the last month.

  • LinkedIn Followers

    201911

  • Daily Change

    0.8%

  • 1 Month Change

    0.8%

  • 3 Month Change

    1.7%

Business Outlook

According to employee reviews, the business outlook among employees at PerkinElmer is 32 out of 100 (bearish), down by -3% over the last month.

  • Business Outlook

    32

  • Change from Previous Month

    3%

  • 3 Month Change

    8.6%

  • YoY Change

    8.6%

LinkedIn Employees

According to LinkedIn, PerkinElmer has 6,345 employees, up by 0.2% over the last month.

  • LinkedIn Employees

    6345

  • Daily Change

    0.2%

  • 1 Month Change

    0.2%

  • 3 Month Change

    0.4%

News Mentions

PerkinElmer was mentioned 1 times in the news yesterday.

  • News Mentions

    1

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    50%

  • YoY Change

    50%

0KHE.L Financials

0KHE.L Key Metrics

  • Total Revenue

    $664.8M

  • Net Income

    $42.2M

  • Earnings per Share

    $0.35

  • Free cash flow

    $118.1M

  • EBITDA

    $72.2M

  • EBITDA Ratio

    0.108655

  • Total Assets

    $12.4B

0KHE.L 2-year Revenue & Income
0KHE.L 2-year Free Cash Flow

0KHE.L Technicals

0KHE.L SMA
0KHE.L RSI

FAQ

What's the current price of PerkinElmer (0KHE.L) Stock?
The price of an PerkinElmer (0KHE.L) share is $100.7.

What's the market cap of PerkinElmer?
The current market cap of PerkinElmer is 11.9B.

Should I buy or sell 0KHE.L?
PerkinElmer shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, PerkinElmer is better viewed as a hold or accumulate position while waiting for further developments.

Is PerkinElmer a good investment?
The current analysis of PerkinElmer's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in PerkinElmer's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.

Is now a good time to buy PerkinElmer (0KHE.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for PerkinElmer stock is currently neutral, suggesting a cautious approach might be wise.

What are some stocks similar to PerkinElmer (0KHE.L) that investors often compare it to?
PerkinElmer (0KHE.L) is often compared to similar stocks such as Lonza Group AG, ANGLE, Diaceutics PLC, genedrive and Verici Dx.

What is the forecast for PerkinElmer's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast PerkinElmer's stock price to be around $96.08 in 2026. Starting from the current price of $100.7, this represents a 4.6% change in price, indicating a bearish outlook for the stock.

How to buy PerkinElmer (0KHE.L) Stock?
PerkinElmer stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy PerkinElmer shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.